Toward measuring effective treatment coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder.

Daniel V VigoJosep Maria HaroIrving HwangSergio Aguilar-GaxiolaJordi AlonsoGuilherme BorgesRonny BruffaertsJose Miguel Caldas-de-AlmeidaGiovanni de GirolamoSilvia FlorescuOye GurejeElie KaramGeorges KaramViviane Kovess-MasfetySing LeeFernando Navarro-MateuAkin OjagbemiJose Posada-VillaNancy A SampsonKate ScottJuan Carlos StagnaroMargreet Ten HaveMaria Carmen VianaChi-Shin WuSomnath ChatterjiPim CuijpersGraham ThornicroftRonald C Kessler

Published in: Psychological medicine (2020)

Decision-makers need to increase the utilization and quality of pharmacotherapy and psychotherapy. Innovations such as telehealth for training and supervision plus non-specialist or community resources to deliver pharmacotherapy and psychotherapy could address these bottlenecks.

Keyphrases

major depressive disorder
bipolar disorder
smoking cessation
mental health
healthcare
palliative care
quality improvement
posttraumatic stress disorder